GSVRX
Price
$14.96
Change
-$0.41 (-2.67%)
Updated
Dec 18 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

GSVRX vs RMFCX

Header iconGSVRX vs RMFCX Comparison
Open Charts GSVRX vs RMFCXBanner chart's image
Goldman Sachs Large Cap Value R
Price$14.96
Change-$0.41 (-2.67%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
GSVRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSVRX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVRX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. GSVRX (446M). RMFCX pays higher dividends than GSVRX: RMFCX (1.69) vs GSVRX (0.83). GSVRX was incepted earlier than RMFCX: GSVRX (17 years) vs RMFCX (23 years). GSVRX is a more actively managed with annual turnover of: 57.00 vs. RMFCX (25.00). GSVRX has a lower initial minimum investment than RMFCX: GSVRX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. GSVRX (9.17). RMFCX return over 5 years is better than : 40.39 vs. GSVRX (10.28).
GSVRXRMFCXGSVRX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years23 years-
Gain YTD7.58611.42366%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets446M104B0%
Annual Yield % from dividends0.831.6949%
Returns for 1 year9.1712.6373%
Returns for 3 years2.3514.1617%
Returns for 5 years10.2840.3925%
Returns for 10 years-3.4261.84-6%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc